Testing protein needs in adults with PKU
Part of Genetic & congenital clinical trials.
This study looks at how much protein people with PKU need. If you have PKU and are 18 or older, you may help researchers understand your body's protein needs better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have been diagnosed with PKU (phenylketonuria) through newborn screening or later in life.
- You must have had genetic testing to confirm your PKU type.
- You cannot be pregnant or have irregular periods.
- You cannot have had recent weight loss or a serious illness in the past 6 months.
- You cannot have claustrophobia or a pacemaker or other implanted electronic device.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how educational, social support, and nutrition help affect pregnancy outcomes and quality of life in women with PKU. It may help you better manage PKU-related needs before and during pregnancy.
This study looks at how taking Palynziq affects your nutrition and health in people with phenylketonuria (PKU). You might benefit by getting careful monitoring while researchers learn how the medicine changes diet-related measurements.
This study tests whether a specific mix of large neutral amino acids (LNAAs) can help adults with classical PKU by lowering phenylalanine levels in the brain. It includes an MRI and PET scan to see how the treatment affects brain activity.
This study looks at how common obesity is in adults with PKU and what factors may contribute to it.
This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.
This study is testing whether a new microtablet form of protein substitute is easy and acceptable for people with PKU to take. If you qualify, you'll take these tablets instead of your current protein substitute and share your experience with the research team.
Hear when a new PKU trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.